Since 1971, the landscape of drug research in the United States has been drastically altered, with severe restrictions placed on the study of substances deemed “most dangerous.” The Controlled Substances Act (CSA), ostensibly implemented for public protection, has instead created a system that inadvertently benefits pharmaceutical companies by maintaining their monopoly on drug manufacturing and distribution.
Cannabis moves fast. New strains appear every season, each promising louder flavors, bigger yields, or…
What do you give someone who already has everything? That’s the question Distinctive Assets, the…
The road into the Mzintlava River Valley is not on any investment map. It bends…
On February 9th, 2026, the New York Times editorial board published a piece titled "It's…
A point-by-point look at SAM’s New York report finds a familiar pattern: selective data, overstated…
"The War on Drugs" is a 12-track musical history project chronicling America's century-long crusade against…